Loading...
•
Dec 31, 2021
Amphastar Q4 2021 Earnings Report
Reported net revenues of $120.9 million and GAAP net income of $19.8 million for the quarter ended December 31, 2021.
Key Takeaways
Amphastar Pharmaceuticals reported strong Q4 2021 results, with net revenues reaching $120.9 million and a GAAP net income of $19.8 million, driven by the growth of higher-margin products.
Net revenues for the fourth quarter were $120.9 million.
GAAP net income for the fourth quarter was $19.8 million, or $0.39 per share.
Adjusted non-GAAP net income for the fourth quarter was $20.8 million, or $0.42 per share.
Financial strength was driven by the continued growth of higher-margin products.
Revenue by Segment
Forward Guidance
The company expects a number of pipeline milestones to be reached in 2022 as it continues to execute the Company’s strategy.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...